Bristol-Myers sees big jumps in 1Q sales, profit
Friday, April 30th, 2010We recommend: no prescription valtrex, no prescription ceftin, no prescription tamoxifen
TRENTON, N.J. — Drugmaker Bristol-Myers Squibb Co. on Thursday reported double-digit jumps in first-quarter sales and lucre, whipping Wall Street expectations, but it lowered its 2010 gain reckon by a ni due to the brownie of the wellness tending modernize.
Still, its shares jumped on the results.
The manufacturer of megahit descent diluent Plavix posted a rattling hefty melioration in first-quarter profits, which jumped 16.5 percentage to $743 meg, or 43 cents per ploughshare, from $638 meg or 32 cents per part, in the outset one-quarter of 2009.